GCM
IMUX icon

Ghisallo Capital Management’s Immunic IMUX Stock Holding History

Ghisallo Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-83,500
Closed -$582K – 238
2025
Q2 		$582K Buy
+83,500
New +$767K 0.02% 175

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ghisallo Capital Management's IMUX Position: Q3 2025 in Review

Ghisallo Capital Management sold out of Immunic (IMUX) in Q3 2025, closing a stake of 83,500 shares — an estimated $582K sold.

Ghisallo Capital Management first reported a position in IMUX in Q2 2025 and held it in 1 quarter. The position peaked at $582K in Q2 2025. 59 funds tracked by Wall St. Rank hold IMUX as of Q3 2025.

  • Ghisallo Capital Management reported no remaining Immunic position as of Q3 2025 after selling out during the quarter.
  • Ghisallo Capital Management sold 83,500 Immunic shares in Q3 2025, an estimated $582K.
  • Ghisallo Capital Management first reported a position in Immunic in Q2 2025 and held it in 1 quarter.
  • Ghisallo Capital Management's Immunic position peaked at $582K in Q2 2025.
  • 59 funds tracked by Wall St. Rank held Immunic as of Q3 2025.

Based on Ghisallo Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.